Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Alexandra Picard Gauci"'
Autor:
Clémence Bertold, Laura Troin, Madleen Chassang, Thierry Passeron, Jérôme Doyen, Henri Montaudié, Alexandra Picard‐Gauci
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 4, Pp 940-943 (2023)
Abstract Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine skin cancer, associated with high mortality. Immune checkpoint inhibitors (ICIs) have demonstrated long‐lasting efficiency for treating advanced MCC. Despite a good safety
Externí odkaz:
https://doaj.org/article/244192f47e7e4833ab1c1440aa6f4cc5
Publikováno v:
JEADV Clinical Practice, Vol 1, Iss 2, Pp 129-131 (2022)
Abstract Background Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous neuroendocrine malignancy. Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for patients with metastatic MCC (mMCC). In mMCC, the response
Externí odkaz:
https://doaj.org/article/edcacaa87e3043dcbf2642351ca2e95e
Autor:
Yann Cheli, Meri K. Tulic, Najla El Hachem, Nicolas Nottet, Arnaud Jacquel, Maeva Gesson, Thomas Strub, Karine Bille, Alexandra Picard-Gauci, Henri Montaudié, Guillaume E. Beranger, Thierry Passeron, Pierre Close, Corine Bertolotto, Robert Ballotti
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-5 (2021)
Abstract Resistances to immunotherapies remains a major hurdle towards a cure for melanoma in numerous patients. An increase in the mesenchymal phenotype and a loss of differentiation have been clearly associated with resistance to targeted therapies
Externí odkaz:
https://doaj.org/article/a109a58f73fa4ac585009c1946fc3fba
Autor:
Thierry Passeron, Alexandre Gérard, Jerome Doyen, Marion Cremoni, Laurent Bailly, Kevin Zorzi, Caroline Ruetsch-Chelli, Vesna Brglez, Alexandra Picard-Gauci, Laura Troin, Vincent L.M. Esnault, Henri Montaudié, Barbara Seitz-Polski
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background Despite significant progress with antiprogrammed cell death protein 1 (PD-1) therapy, a substantial fraction of metastatic melanoma patients show upfront therapy resistance. Biomarkers for outcome are missing and the association of baselin
Externí odkaz:
https://doaj.org/article/36baee766c114b4fbed2bdf963c3dadd
Autor:
Marius Ilié, Elisabeth Lantéri, Emmanuel Chamorey, Brice Thamphya, Marame Hamila, Henri Montaudié, Alexandra Picard-Gauci, Sophie Gardrat, Thierry Passeron, Sandra Lassalle, Elodie Long-Mira, Julien Cherfils-Vicini, Eric Gilson, Véronique Hofman, Paul Hofman
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
The outcome of patients with cutaneous melanoma has been strongly modified by recent advances obtained with Immune Checkpoint Inhibitors (ICIs). However, despite this breakthrough, durable response to ICIs is limited to a subset of patients. We inves
Externí odkaz:
https://doaj.org/article/bfd4f825455c4ae1a40fb600d495b127
Autor:
Elodie Long-Mira, Alexandra Picard-Gauci, Sandra Lassalle, Véronique Hofman, Salomé Lalvée, Virginie Tanga, Katia Zahaf, Christelle Bonnetaud, Virginie Lespinet, Olivier Camuzard, Henri Montaudié, Gilles Poissonnet, Thierry Passeron, Marius Ilié, Paul Hofman
Publikováno v:
Diagnostics, Vol 12, Iss 3, p 751 (2022)
Testing for the BRAF mutation is mandatory for the management of patients with locally advanced or metastatic melanoma. Molecular analysis based on DNA sequencing remains the gold-standard method for the screening of the different BRAF mutations. The
Externí odkaz:
https://doaj.org/article/c45daa640a564eeda293675f6eb69b78
Autor:
Yann Cheli, Meri K. Tulic, Najla El Hachem, Nicolas Nottet, Arnaud Jacquel, Maeva Gesson, Thomas Strub, Karine Bille, Alexandra Picard-Gauci, Henri Montaudié, Guillaume E. Beranger, Thierry Passeron, Pierre Close, Corine Bertolotto, Robert Ballotti
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-1 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/046931caca0a4d15a0880c5b9c1c5cee
Autor:
Frederic Reinier, Hélène Martin, Thierry Passeron, Henri Montaudié, Guillaume E. Beranger, Alexandra Picard-Gauci, Robert Ballotti, Laura Troin, Nicolas Nottet
Publikováno v:
Pigment Cell & Melanoma Research. 34:978-983
Immune checkpoint inhibition (ICI) treatments improve outcomes for metastatic melanoma; however, up to 60% of treated patients do not respond to ICI and/or develop immune-related adverse events (irAEs). Currently, robust and reliable biomarker to pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01c3231231ca50c138dfa83e20bb8eb5
https://doi.org/10.1111/pcmr.12958
https://doi.org/10.1111/pcmr.12958
Autor:
Gilles Poissonnet, Alexandra Picard-Gauci, Laurent Mortier, Julien Viotti, Julie De Quatrebarbes, Regis Kaphan, Maria Kogay, Henri Montaudié, Caroline Robert, Caroline Dutriaux, Anne-Bénédicte Duval-Modeste, Nicolas Dupin, Stéphane Dalle, Andrea Stefan, Patrick Combemale, Florence Brunet-Possenti, Frederic Peyrade
Publikováno v:
Oncotarget
There is no standard of care for unresectable cutaneous squamous cell carcinoma (cSCC). Chemotherapy, alone or combined with radiotherapy, is commonly used mostly as palliative treatment; moreover, its poor safety profile limits its use most of the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f391a692da45f1e8960b2cac3e220dd
https://doi.org/10.18632/oncotarget.27434
https://doi.org/10.18632/oncotarget.27434
Autor:
Manon, Blaise, Nathalie, Cardot-Leccia, Barbara, Seitz-Polski, Alexandra, Picard-Gauci, Clémence, Bertold, Thierry, Passeron, Henri, Montaudié
Publikováno v:
JAMA Dermatology. 159:112
This case report describes a 78-year old woman with a stage IIA BRAF wild-type melanoma on the left leg who experienced a grade 2 vitiligo, a marked skin thickening, and painful swelling of the limbs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8976bdaee0ec2e81810400d2018abc63
https://doi.org/10.1001/jamadermatol.2022.5146
https://doi.org/10.1001/jamadermatol.2022.5146